It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Insects lack the adaptive, antibody mediated responses of vertebrates, yet they possess a robust innate immune system capable of defending the host against pathogens. Immune priming has been observed in multiple insect species, wherein exposure to a pathogen provides protection against subsequent infections by the pathogen. Less frequently, heterologous immune priming has been observed where exposure to one bacterial species provides protection against other species. We determined that Rhodococcus rhodnii, a gut symbiont of the kissing bug Rhodnius prolixus, induces a strong heterologous immune priming effect, while axenic bugs lacking any gut bacteria are highly susceptible to pathogens in their hemolymph. Commensal Escherichia coli provides a less robust protective effect than R. rhodnii. R. rhodnii must be alive within the insect as dead bacteria do not stimulate immune priming and pathogen resistance. Removal of R. rhodnii from the gut reduces resistance to pathogens while restoring it to otherwise axenic bugs improves resistance to pathogens, though not completely. R. rhodnii and E. coli activate both the Imd and Toll pathways, indicating cross-activation of the pathways and demonstrating the canonical Drosophila immune response has diverged in Hemiptera. Silencing of either pathway leads to a loss of the protective effect. Several antimicrobial peptides are induced in the fat body by presence of gut bacteria. When E. coli is in the gut, expression of antimicrobial peptides is often higher than when R. rhodnii, though R. rhodnii stimulates proliferation of hemocytes and induce a stronger melanization response. Hemolymph from R. rhodnii bugs has a greater ability to convert the melanin precursor DOPA to melanization products than axenic or E. coli-harboring bugs. These results demonstrate that R. rhodnii’s benefits to its host extend beyond nutritional provisioning, playing an important role in the host immune system.
Competing Interest Statement
The authors have declared no competing interest.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer





